CV2 LIPID LEVELSAND NCEPATP-III LDL-CHOLESTEROL GOAL ATTAINMENT IN PATIENTS NEWLY-INITIATED ON ROSUVASTATIN ORATORVASTATIN
Abstract
Authors
MF Bullano SA Kamat SA Williams DA Wertz MJ Cziraky VJ Willey
MF Bullano SA Kamat SA Williams DA Wertz MJ Cziraky VJ Willey
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now